Cargando…

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?

COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahnert, Kathrin, Fischer, Carolina, Alter, Peter, Trudzinski, Franziska, Welte, Tobias, Behr, Jürgen, Herth, Felix, Kauczor, Hans-Ulrich, Bals, Robert, Watz, Henrik, Rabe, Klaus, Söhler, Sandra, Kokot, Inge, Vogelmeier, Claus, Jörres, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931494/
https://www.ncbi.nlm.nih.gov/pubmed/36526266
http://dx.doi.org/10.1055/a-1966-0848
Descripción
Sumario:COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included a comprehensive functional and clinical characterisation. On the basis of this detailed data set, it was possible to address a large number of clinical questions. These questions ranged from the prescription of medication, the detailed analysis of comorbidities, in particular cardiovascular disease, and biomarker assessment to radiological and health-economic aspects. Currently, more than 60 publications of COSYCONET data are internationally available. The present overview provides a description of all the results that were obtained, focussing on the relationship between different clinical and functional aspects as well as their potential practical consequences. In addition, information on the follow-up study COSYCONET 2 is given.